Evidence map›Paper›PMID 18768880›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2008

PIR-B-deficient mice are susceptible to Salmonella infection.

Ikuko Torii, Satoshi Oka, Muneki Hotomi, William H Benjamin, Toshiyuki Takai, John F Kearney, David E Briles, Hiromi Kubagawa

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. PIR-B Regulates CD4Cellular and molecular gastroenterology and hepatology · 2021
    Article
  3. Review
  4. Article
  5. An Unmutated IgM Response to the Vi Polysaccharide ofJournal of immunology (Baltimore, Md. : 1950) · 2018
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Role of PIR-B in autoimmune glomerulonephritis.Journal of biomedicine & biotechnology · 2011
    Review
  15. Molecular underpinning of B-cell anergy.Immunological reviews · 2010
    Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 3 countries.

Ikuko ToriiDepartment of Pathology, University of Alabama at Birmingham, Birmingham, AL 35294-3300, USA.
Satoshi Oka
Muneki Hotomi
William H Benjamin
Toshiyuki Takai
John F Kearney
David E Briles
Hiromi Kubagawa
University of Alabama at Birmingham · USTohoku University · JP

Funding

Regulation of B cell Clonal Diversity and Its Role in DiseaseR01AI014782 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KEARNEY, JOHN FRANKLIN · 1985 to 2020
$7.1M
PspA: A Potential Pneumococcal Vaccine ComponentR01AI021548 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BRILES, DAVID E · 1985 to 2012
$6.0M
Studies of Paired Immunoglobulin-Like ReceptorsR01AI042127 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KUBAGAWA, HIROMI · 1998 to 2010
$2.2M
PspA mechanisms of humoral immunity, functional assays, and optimal vaccine constR56AI021548 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BRILES, DAVID E · 2014 to 2014
$543k
REGULATION OF B CELL CLONAL DIVERSITYR21AI014782 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KEARNEY, JOHN FRANKLIN · 2000 to 2000
$179k
NOVEL PAIR OF IMMUNOGLOBULIN LIKE RECEPTORSR21AI042127 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KUBAGAWA, HIROMI · 1998 to 1998
–
NIAID NIH HHS AI14782NIAID NIH HHS AI21548NIAID NIH HHS AI42127NIAID NIH HHS R01 AI014782NIAID NIH HHS R01 AI021548NIAID NIH HHS R01 AI042127NIAID NIH HHS R21 AI014782NIAID NIH HHS R56 AI021548
6 · The paper itself

Abstract

Paired Ig-like receptors of activating (PIR-A) and inhibitory (PIR-B) isoforms are expressed by many hematopoietic cells, including B lymphocytes and myeloid cells. To determine the functional roles of PIR-A and PIR-B in primary bacterial infection, PIR-B-deficient (PIR-B(-/-)) and wild-type (WT) control mice were injected i.v. with an attenuated strain of Salmonella enterica Typhimurium (WB335). PIR-B(-/-) mice were found to be more susceptible to Salmonella infection than WT mice, as evidenced by high mortality rate, high bacterial loads in the liver and spleen, and a failure to clear bacteria from the circulation. Although blood levels of major cytokines and Salmonella-specific Abs were mostly comparable in the two groups of mice, distinct patterns of inflammatory lesions were found in their livers at 7-14 days postinfection: diffuse spreading along the sinusoids in PIR-B(-/-) mice vs nodular restricted localization in WT mice. PIR-B(-/-) mice have more inflammatory cells in the liver but fewer B cells and CD8(+) T cells in the spleen than WT mice at 14 days postinfection. PIR-B(-/-) bone marrow-derived macrophages (BMMphi) failed to control intracellular replication of Salmonella in vitro, in part due to inefficient phagosomal oxidant production, when compared with WT BMMphi. PIR-B(-/-) BMMphi also produced more nitrite and TNF-alpha upon exposure to Salmonella than WT BMMphi did. These findings suggest that the disruption of PIR-A and PIR-B balance affects their regulatory roles in host defense to bacterial infection.

Indexed as

AnimalsAntibodies, BacterialCytokinesFemaleGenetic Predisposition to DiseaseInflammation MediatorsLiverMaleMiceMice, Inbred C57BLMice, KnockoutProtein IsoformsReceptors, ImmunologicSalmonella Infections, AnimalSalmonella typhimuriumSpleenAntibodies, BacterialCytokinesInflammation MediatorsPira1 protein, mousePirb protein, mouseProtein IsoformsReceptors, Immunologic

Identifiers

PMID18768880
PMCPMC2613810
OpenAlexW2106654764

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.